Puma Biotechnology, Inc. (PBYI) Financials

PBYI Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 192.7 million 64.3 million
Dec. 31, 2025 216.3 million 86.0 million
Sept. 30, 2025 202.9 million 87.6 million
June 30, 2025 194.9 million 90.2 million

PBYI Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 15.4 million 1.9 million
Dec. 31, 2025 14.5 million 1.6 million
Sept. 30, 2025 9.7 million 1.7 million
June 30, 2025 14.1 million 1.6 million

PBYI Net Income

No data available :(

PBYI Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 101.6 million 4.5 million -
Dec. 31, 2025 97.5 million - 6.0 million
Sept. 30, 2025 94.4 million - 7.3 million
June 30, 2025 96.0 million 10.9 million 4.4 million

PBYI Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 50.8 million
Dec. 31, 2025 51.5 million
Sept. 30, 2025 50.9 million
June 30, 2025 50.1 million

PBYI Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 19.8 million 18.4 million -
Dec. 31, 2025 36000 16.8 million 18.4 million -
Sept. 30, 2025 26000 15.9 million 17.0 million -
June 30, 2025 20000 15.5 million 18.4 million -

PBYI Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 44.8 million 10.4 million
Dec. 31, 2025 75.5 million 23.1 million
Sept. 30, 2025 54.5 million 12.2 million
June 30, 2025 52.4 million 12.3 million

PBYI Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PBYI

Price: $6.81

52 week price:
2.85
7.90

Earnings Per Share: 0.48 USD

P/E Ratio: 14.94

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 234700

Ebitda: -76.5 million

Market Capitalization: 364.9 million

Links: